Biomedical Innovation Around the World

Overview

The Duke-Margolis has engaged with multiple stakeholders to advance work on biomedical innovation and provide guidance on best practices to address regulatory challenges.

See specific projects below

Mapping Global Health Research & Development

This study aimed to identify how the US government funding decisions are determined and explore how the US government could improve its support for global health research and product development.

Funder: Global Health Technologies Coalition

Duke Lead: Duke's Center for Policy Impact in Global Health

Transferable Exclusivity Voucher

Duke-Margolis is examining whether a transferable exclusivity voucher (TEV) program for neglected tropical diseases is desirable and feasible, and if so, how to implement it. The research team conducted a stakeholder analysis, including over 20 interviews and a roundtable, and literature review.

Funder: Gates Foundation

Duke Lead: Margolis

Medical product regulatory reform in China

The Center has engaged with the National Medical Product Administration to help bring clinical trials and evidentiary standards in-line with international best practices.